No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bortezomib / administration & dosage
-
Bortezomib / adverse effects
-
Dexamethasone / administration & dosage
-
Dexamethasone / adverse effects
-
Diarrhea / chemically induced
-
Humans
-
Hydroxamic Acids / administration & dosage
-
Hydroxamic Acids / adverse effects
-
Indoles / administration & dosage
-
Indoles / adverse effects
-
Induction Chemotherapy / methods
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / therapy
-
Nausea / chemically induced
-
Neutropenia / chemically induced
-
Panobinostat
-
Preoperative Period
-
Stem Cell Transplantation
-
Thrombocytopenia / chemically induced
-
Transplantation, Autologous
-
Treatment Outcome
-
Vomiting / chemically induced
Substances
-
Hydroxamic Acids
-
Indoles
-
Bortezomib
-
Dexamethasone
-
Panobinostat